Extended-Duration Low-Dose Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism Interventions:   Drug: Apixaban 2.5 MG;   Drug: Placebo oral tablet Sponsor:   Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials